198 related articles for article (PubMed ID: 29766398)
21. 18F-FDG PET/CT in Hepatosplenic Gamma-Delta T-Cell Lymphoma.
Quak E; Salaun V; Le Naoures C; Fruchart C
Clin Nucl Med; 2015 Sep; 40(9):730-1. PubMed ID: 26053728
[TBL] [Abstract][Full Text] [Related]
22. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
23. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
[TBL] [Abstract][Full Text] [Related]
24. Hepatosplenic alphabeta T cell lymphoma.
Nagai Y; Ikegame K; Mori M; Inoue D; Kimura T; Shimoji S; Togami K; Tabata S; Kurata M; Imai Y; Matsushita A; Nagai K; Ogawa H; Takahashi T
Int J Clin Oncol; 2010 Apr; 15(2):215-9. PubMed ID: 20217452
[TBL] [Abstract][Full Text] [Related]
25. Hepatosplenic T-cell lymphoma in a young immunocompetent man.
Petrova M; Gomes MM; Carda JP; Pereira de Moura J
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033291
[TBL] [Abstract][Full Text] [Related]
26. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
27. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
[TBL] [Abstract][Full Text] [Related]
28. Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk.
Parakkal D; Sifuentes H; Semer R; Ehrenpreis ED
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1150-6. PubMed ID: 21941193
[TBL] [Abstract][Full Text] [Related]
29. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors.
Yabe M; Miranda RN; Medeiros LJ
Hum Pathol; 2018 Apr; 74():5-16. PubMed ID: 29337025
[TBL] [Abstract][Full Text] [Related]
30. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.
Mackey AC; Green L; Liang LC; Dinndorf P; Avigan M
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):265-7. PubMed ID: 17255842
[TBL] [Abstract][Full Text] [Related]
31. Fulminant liver failure induced by hepatosplenic alphabeta T-cell lymphoma.
Petersen-Benz C; Hoffmann N; Beckurts T; Goeser T; Steffen HM; Dries V
Z Gastroenterol; 2003 Nov; 41(11):1083-6. PubMed ID: 14648377
[TBL] [Abstract][Full Text] [Related]
32. Hepatosplenic T-Cell Lymphoma in an Immunocompetent Male with Central Nervous System Invasion: A Rare Clinical Entity.
Wu F; Pan Y; Wang H; Tao Q; An F; Zhang J; Zhai Z
Cytometry B Clin Cytom; 2019 Nov; 96(6):475-479. PubMed ID: 30500103
[TBL] [Abstract][Full Text] [Related]
33. Expect the unexpected - Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener.
Chauhan R; Tyagi S; Mirgh S; Mishra P; Seth T; Mahapatra M; Pati H; Saxena R
Indian J Pathol Microbiol; 2018; 61(2):275-277. PubMed ID: 29676377
[TBL] [Abstract][Full Text] [Related]
34. Hepatosplenic T-cell lymphoma: a rare but challenging entity.
Pro B; Allen P; Behdad A
Blood; 2020 Oct; 136(18):2018-2026. PubMed ID: 32756940
[TBL] [Abstract][Full Text] [Related]
35. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
[No Abstract] [Full Text] [Related]
36. A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.
Albayrak M; Balcik OS; Alan S; Dıncer SL; Yüksel MK; Albayrak A
Pathol Oncol Res; 2011 Jun; 17(2):421-3. PubMed ID: 21197592
[No Abstract] [Full Text] [Related]
37. [26-year-old patient with ulcerative colitis and anemia].
Kreth F; Neumann S; Hegenbart U; Mössner J; Caca K
Internist (Berl); 2004 Feb; 45(2):217-20. PubMed ID: 14991164
[TBL] [Abstract][Full Text] [Related]
38. Hepatosplenic T-cell lymphoma: A case series.
Ashmore P; Patel M; Vaughan J; Wiggill T; Willem P; van den Berg E; Philip V; Lakha A
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):78-84. PubMed ID: 25450840
[TBL] [Abstract][Full Text] [Related]
39. Hepatosplenic T-cell lymphoma mimicking bone marrow metastasis.
Benayoun E; Wagner-Ballon O
Blood; 2015 Oct; 126(17):2071. PubMed ID: 26788568
[No Abstract] [Full Text] [Related]
40. Coexistent hairy cell leukaemia and hepatosplenic T-cell lymphoma: a case report.
Gasljevic G; Kloboves-Prevodnik V; Gazic B; Vovk M
Diagn Pathol; 2014 Mar; 9():58. PubMed ID: 24621139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]